Skip to main content
. Author manuscript; available in PMC: 2012 Nov 1.
Published in final edited form as: Environ Res. 2011 Aug 25;111(8):1236–1242. doi: 10.1016/j.envres.2011.07.012

Table 1.

Selected demographic, exposure, and health outcome measures from the fourth evaluation in 712 current and former lead workersa

Characteristic All Participants
N (%)
Female 149 (20.9)
Diabetes 27 (3.8)
Hypertension 86 (12.1)
Former lead workers 234 (32.9)
Smoking
 Never 242 (34.0)
 Current 310 (43.5)
 Former 160 (22.5)
Alcohol use
 Never 109 (15.3)
 Current 571 (80.2)
 Former 32 (4.5)
Education
 Less than middle school graduate 180 (25.3)
 Less than high school graduate 182 (25.6)
 High school graduate 294 (41.3)
Median Mean (SD) Range
Age, years 46.7 47.6 (7.9) 24.1–71.3
BMI, kg/m2 24.2 24.2 (2.8) 15.6–33.3
Systolic blood pressure, mm Hg 121.5 123.7 (15.5) 90.5–213.3
Diastolic blood pressure, mm Hg 74.3 75.2 (12.0) 46.0–147.0
Urine cadmium, μg/g creatininea 0.84 1.02 (0.65) 0.17–4.63
Urine cadmium, μg/Lb 0.65 0.89 (0.73) 0.06–5.4
Urine creatinine, mg/dL 82.2 94.4 (58.1) 11.8–342.7
Blood lead, μg/dL 21.4 23.1 (14.1) 1.9–74.4
Tibia lead, μg Pb/g bone mineral 19 26.6 (28.9) −12–231
Lead job duration, years 13.2 13.1 (7.3) 0.23–37.4
Serum creatinine, mg/dl 0.87 0.87 (0.15) 0.42–1.53
Serum cystatin C, mg/L 0.72 0.73 (0.12) 0.50–2.35
Single var. cystatin C eGFR, mL/min/1.73 m2 113.9 113.7 (16.7) 27.8–176.3
Multi-var. cystatin C eGFR, mL/min/1.73 m2 112.8 112.0 (17.7) 28.1–186.3
Dual biomarker eGFR, mL/min/1.73 m2 105.8 106.1 (17.5) 24.3–174.5
MDRD eGFR, mL/min/1.73 m2 95.5 97.4 (19.2) 23.6–189.7
a

modified from Weaver et al., 2011

b

molybdenum-corrected